Navigation Links
Amifostine Renders Cancer More Susceptible To Radiation

The drug amifostine has been found to ease most of the side affects associated with radiation therapy and also make cancer more susceptible to radiation, according to doctors in Brazil. Their findings are published in the March 1// issue of the International Journal of Radiation

Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. The reserachers decided to check out data from already published studies to evaluate if adding amifostine to radiation therapy decreased the occurrence of side effects like difficulty in swallowing, dry mouth, lung inflammation, bladder inflammation, problems with the esophagus and inflammation of the mucous membranes. Sometimes these side effects cause significant problems and even force the treatment to be stopped while the patient recovers. The study also wanted to find out if amifostine protected the cancer from radiation. The researchers evaluated the effects of amifostine in 14 randomized, controlled trials in which 1,451 patients were enrolled. These patients were split into two groups, one receiving radiation alone, while the other received radiation as well as amifostine. It was found that contrary to fears, amifostine rendered the tumor more susceptible to radiation and patients on amifostine were more likely to have their cancer completely cured by radiation. But amifostine did have some side effects like nausea and vomiting. "Our research shows that adding amifostine to radiation therapy helps reduce side effects while at the same time making the radiation treatments more effective at killing the cancer cells," said Andre Deeke Sasse, M.D., a radiation oncologist at Nucleo Brasileiro de Oncologia Baseada em Evidencias in Sao Paolo, Brazil. "We recommend that patients undergoing radiation therapy for cancer ask their doctor about adding amifostine to their treatment." For more information on radiation therapy for cancer, please visit Contact: Nick Lashinsky 703-227-0185 American Society for Therapeutic Radiology and Oncology Source: Eurekalert

Related medicine news :

1. Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:

(Date:12/1/2015)... PITTSBURGH, PA (PRWEB) , ... December 01, 2015 ... ... or imaging facilities, radiographic technicians must mark the film for accurate interpretation by ... keep track of. Fortunately, an inventor from Sacramento, Calif., has found a way ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, ... addresses a main “pain point” for merging or aligning healthcare provider organizations—when mergers ... is signed. This quick-read guidance suggests that failing to recognize the power ...
(Date:12/1/2015)... ... 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, ... , The order will be from the China Disabled Persons’ Federation, a central government ... effective solution for children and adults suffering from severe and profound hearing loss ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... companies, announced today that it has officially launched a sleek, mobile-ready and user-centric ... that his company’s new website clearly outlines the benefits that its SEO services ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon ... today that top-line data from its TELECAST ... etiprate in treating carcinoid syndrome in cancer ... the clinical benefit observed in its pivotal ... as a companion to TELESTAR primarily to ...
(Date:12/1/2015)... 2015 North America ... with analysis and forecast of revenue. --> ... segments the concerned market with analysis and forecast of ... Report "North American Orthobiologics Market by Type (Bone Allograft, ... Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) ...
(Date:12/1/2015)... , December 1, 2015 ... the addition of the  "2016 Shigella ... Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, ... Japan"  report to their offering. ... the addition of the  "2016 Shigella ...
Breaking Medicine Technology: